The debate over transperineal vs. transrectal biopsies continues. There have been four randomized trials in the past year alone with somewhat contradictory results.
Active Surveillance Patients International’s monthly webinar is focused on these issues with researcher, Sanoj Punnen, MD, Professor of Urologic Oncology at the University of Miami, joining us as our featured speaker.
Dr. Punnen is Vice Chair of Research, Desai Sethi Urology Institute, and Co-Chair of Genitourinary Site Disease Group, Sylvester Comprehensive Cancer Center University of Miami Leonard M. Miller School of Medicine. Dr. Punnen’s research interest is in prostate cancer, primarily related to imaging, genomic, and molecular biomarkers in the detection, risk stratification, and monitoring of prostate cancer.
He is lead investigator on two prospective clinical trials validating a novel blood-based biomarker called the 4KScore test for predicting the risk of clinically significant prostate cancer and need for biopsy of the prostate. He is also the Principal Investigator on an ongoing NCI-funded prospective clinical trial examining the impact of prostate MRI and tissue-based genomic prognostic signatures in men undergoing Active Surveillance for prostate cancer.
10:20 Sanoj Punnen, MD
51:58 Q & A
Please note: During the presentation, a short video clip of a transperineal biopsy being performed is shown. Please consider your environment when viewing this. The presenter does issue a warning before the video starts.